Methylenedioxytrimethylamphetamine

Chemical compound

Methylenedioxytrimethylamphetamine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Methylenedioxytrimethylamphetamine (MDTA) is a psychoactive drug of the amphetamine class. It is a derivative of methylenedioxyamphetamine (MDA) and is chemically related to methylenedioxymethamphetamine (MDMA), commonly known as ecstasy. MDTA is known for its stimulant and hallucinogenic effects, although it is less well-known and less studied than its more famous relatives.

Chemical structure and properties

Chemical structure of Methylenedioxytrimethylamphetamine

MDTA is a member of the substituted amphetamines class, characterized by the presence of a methylenedioxy group attached to the phenyl ring. The chemical structure of MDTA is similar to that of MDMA, with the primary difference being the presence of an additional methyl group on the nitrogen atom. This structural modification influences the drug's pharmacological properties and its interaction with neurotransmitter systems in the brain.

Pharmacology

MDTA acts primarily as a serotonin and dopamine releasing agent. It increases the levels of these neurotransmitters in the synaptic cleft by promoting their release from presynaptic neurons and inhibiting their reuptake. This action is responsible for the drug's mood-enhancing and stimulant effects. The increased serotonin levels can lead to feelings of euphoria, emotional closeness, and altered sensory perception, while the increased dopamine levels contribute to increased energy and alertness.

Effects

The effects of MDTA are similar to those of other entactogens and stimulants. Users may experience:

• Euphoria
• Increased sociability and empathy
• Enhanced sensory perception
• Increased energy and alertness
• Mild hallucinations

The duration of effects typically lasts between 4 to 6 hours, depending on the dose and individual metabolism.

Risks and side effects

As with other psychoactive substances, the use of MDTA carries potential risks and side effects. These may include:

• Increased heart rate and blood pressure
• Anxiety and paranoia
• Insomnia
• Jaw clenching and teeth grinding
• Nausea

Long-term use or high doses can lead to more severe health issues, including neurotoxicity and serotonin syndrome.

Legal status

MDTA is classified as a controlled substance in many countries due to its potential for abuse and lack of medical use. It is illegal to manufacture, possess, or distribute MDTA without a license or prescription.

Related pages

• Amphetamine
• Methylenedioxyamphetamine (MDA)
• Methylenedioxymethamphetamine (MDMA)
• Psychoactive drug
• Serotonin
• Dopamine